ACCESSION: MSBNK-SMB_Measured-HSA015P0116005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 22
COMMENT: RAW_SPEC {'EL22_pos_1425': {'bp': 2753687.0, 'sum': 4844457.0}, 'EL19_pos_1431': {'bp': 2620824.0, 'sum': 4858979.0}, 'EL23_pos_1425': {'bp': 2530012.0, 'sum': 4258578.0}, 'EL20_pos_1419': {'bp': 2434710.0, 'sum': 4384683.0}, 'EL21_pos_1419': {'bp': 2335318.0, 'sum': 4325387.0}, 'EL02_pos_1425': {'bp': 2291218.0, 'sum': 4359469.0}, 'EL08_pos_1425': {'bp': 2270596.0, 'sum': 3910991.0}, 'EL05_pos_1425': {'bp': 2213515.0, 'sum': 4314472.0}, 'EL14_pos_1425': {'bp': 2177823.0, 'sum': 3854057.0}, 'EL15_pos_1419': {'bp': 2059798.0, 'sum': 4009624.0}, 'EL13_pos_1425': {'bp': 2046799.0, 'sum': 4014616.0}, 'EL04_pos_1431': {'bp': 2014117.0, 'sum': 3693419.0}, 'EL18_pos_1425': {'bp': 2012227.0, 'sum': 3507714.0}, 'EL11_pos_1425': {'bp': 1955841.0, 'sum': 3848387.0}, 'EL17_pos_1413': {'bp': 1935959.0, 'sum': 3778439.0}, 'EL01_pos_1425': {'bp': 1896607.0, 'sum': 3555065.0}, 'EL09_pos_1425': {'bp': 1895590.0, 'sum': 3785832.0}, 'EL16_pos_1425': {'bp': 1870879.0, 'sum': 3653384.0}, 'EL06_pos_1431': {'bp': 1750151.0, 'sum': 3719870.0}, 'EL10_pos_1425': {'bp': 1732161.0, 'sum': 3390611.0}, 'EL07_pos_1425': {'bp': 1730213.0, 'sum': 3435145.0}, 'EL24_pos_1431': {'bp': 1561063.0, 'sum': 3118257.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 116.107381
COMMENT: PRECURSOR_M/Z_STDEV 0.000038
COMMENT: PRECURSOR_IN_MS1 mz 116.106987; int 999.000; delta(ppm) 0.686509
COMMENT: PROPOSED_CHARGE_STATE +1; mz 117.110272; int 66.882; cor 0.868
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.035; C6H13NO; [M+H]+; delta(ppm) -0.034752
COMMENT: PROPOSED_MF MS-FINDER 4.914; C6H13NO; [M+H]+; delta(ppm) -0.038551
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.804; C6H13NO; [M+H]+; delta(ppm) -0.038551
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.510; C4H11N4; [M+H]+; delta(ppm) 11.525603
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H13NO; [M+H]+; delta(ppm) -0.038551
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.167; CQTRUFMMCCOKTA-UHFFFAOYSA-N; [M+H]+; CC(=O)CC(C)(C)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.125; BAUWRHPMUVYFOD-UHFFFAOYSA-N; [M+H]+; CN1CCC(CC1)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.114; XBXHCBLBYQEYTI-UHFFFAOYSA-N; [M+H]+; C1CNCCC1CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.956; SJCBWLJRMCOJEC-UHFFFAOYSA-N; [M+H]+; CC(C)N(C)C(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.954; PRAYXGYYVXRDDW-UHFFFAOYSA-N; [M+H]+; OCC1NCCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.282; BAUWRHPMUVYFOD-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.189; CHPRFKYDQRKRRK-LURJTMIESA-N; [M+H]+; (S)-2-(methoxymethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.155; XBRDBODLCHKXHI-UHFFFAOYSA-N; [M+H]+; epolamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.097; VTGXVUQXDHXADV-UHFFFAOYSA-N; [M+H]+; UNPD175725
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.078; PRAYXGYYVXRDDW-UHFFFAOYSA-N; [M+H]+; (piperidin-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.027; HVCNXQOWACZAFN-UHFFFAOYSA-N; [M+H]+; UNPD58183
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.008; XBXHCBLBYQEYTI-UHFFFAOYSA-N; [M+H]+; piperidin-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.985; SJCBWLJRMCOJEC-UHFFFAOYSA-N; [M+H]+; UNPD162962
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.967; IMLXLGZJLAOKJN-UHFFFAOYSA-N; [M+H]+; trans-4-aminocyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.942; PQMCFTMVQORYJC-UHFFFAOYSA-N; [M+H]+; CNP0441697
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.898; HNVIQLPOGUDBSU-UHFFFAOYNA-N; [M+H]+; 2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.891; IPBPLHNLRKRLPJ-UHFFFAOYSA-N; [M+H]+; 1-(oxan-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.886; VDQMVRFHUYAKJL-UHFFFAOYSA-N; [M+H]+; N-(2-Methylpropyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.866; CQTRUFMMCCOKTA-UHFFFAOYSA-N; [M+H]+; UNPD66236
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.794; GYLDXXLJMRTVSS-UHFFFAOYSA-N; [M+H]+; N-(3-Methylbutyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.786; QCAAXUQRSHUEHU-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpentanal
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.671; TZJGKUCHNFFHGN-ZCFIWIBFSA-N; [M+H]+; 1-Amino-1-Carbonyl Pentane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.611; ZKALVNREMFLWAN-UHFFFAOYSA-N; [M+H]+; N-(4-methylpentan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.247; BWMRKZGGMCOFCY-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-(methylamino)butanal
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.184; ACMPWZQOUILVFB-UHFFFAOYSA-N; [M+H]+; UNPD195892
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.184; NTLKAXQBFYZMAH-MLHKIVSYNA-N; [M+H]+; UNPD138482
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.184; QVEMWYGBLHQEAK-UHFFFAOYSA-N; [M+H]+; UNPD19435
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.184; SIMLCFANWCDGAF-MLHKIVSYNA-N; [M+H]+; UNPD44155
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.184; ALBYIUDWACNRRB-UHFFFAOYSA-N; [M+H]+; hexanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.184; ZOFRRNUENOHELM-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpentanal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CQTRUFMMCCOKTA-UHFFFAOYSA-N; [M+H]+; UNPD66236
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.761; SJCBWLJRMCOJEC-UHFFFAOYSA-N; [M+H]+; UNPD162962
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.737; CHPRFKYDQRKRRK-LURJTMIESA-N; [M+H]+; (S)-2-(methoxymethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.737; HVCNXQOWACZAFN-UHFFFAOYSA-N; [M+H]+; UNPD58183
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.737; BAUWRHPMUVYFOD-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.737; PRAYXGYYVXRDDW-UHFFFAOYSA-N; [M+H]+; (piperidin-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.731; HNVIQLPOGUDBSU-UHFFFAOYNA-N; [M+H]+; 2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; TZJGKUCHNFFHGN-ZCFIWIBFSA-N; [M+H]+; 1-Amino-1-Carbonyl Pentane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; IMLXLGZJLAOKJN-UHFFFAOYSA-N; [M+H]+; trans-4-aminocyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; QCAAXUQRSHUEHU-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpentanal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; XBXHCBLBYQEYTI-UHFFFAOYSA-N; [M+H]+; piperidin-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; IPBPLHNLRKRLPJ-UHFFFAOYSA-N; [M+H]+; 1-(oxan-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; PQMCFTMVQORYJC-UHFFFAOYSA-N; [M+H]+; CNP0441697
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.628; GYLDXXLJMRTVSS-UHFFFAOYSA-N; [M+H]+; N-(3-Methylbutyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.628; VDQMVRFHUYAKJL-UHFFFAOYSA-N; [M+H]+; N-(2-Methylpropyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.596; ZKALVNREMFLWAN-UHFFFAOYSA-N; [M+H]+; N-(4-methylpentan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.590; XBRDBODLCHKXHI-UHFFFAOYSA-N; [M+H]+; epolamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.558; ZOFRRNUENOHELM-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpentanal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.558; BWMRKZGGMCOFCY-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-(methylamino)butanal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.552; ACMPWZQOUILVFB-UHFFFAOYSA-N; [M+H]+; UNPD195892
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.552; NTLKAXQBFYZMAH-MLHKIVSYNA-N; [M+H]+; UNPD138482
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.552; ALBYIUDWACNRRB-UHFFFAOYSA-N; [M+H]+; hexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.544; VTGXVUQXDHXADV-UHFFFAOYSA-N; [M+H]+; UNPD175725
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QVEMWYGBLHQEAK-UHFFFAOYSA-N; [M+H]+; UNPD19435
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SIMLCFANWCDGAF-MLHKIVSYNA-N; [M+H]+; UNPD44155
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.230; HVCNXQOWACZAFN-UHFFFAOYSA-N; [M+H]+; 4-ethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.742; ALBYIUDWACNRRB-UHFFFAOYSA-N; [M+H]+; hexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.171; AJFDBNQQDYLMJN-UHFFFAOYSA-N; [M+H]+; N,N-diethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.873; HNVIQLPOGUDBSU-UHFFFAOYSA-N; [M+H]+; 2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.688; PQMCFTMVQORYJC-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.569; XBRDBODLCHKXHI-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.554; IMLXLGZJLAOKJN-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.429; JWCDUUFOAZFFMX-UHFFFAOYSA-N; [M+H]+; 2-ethenoxy-N,N-dimethylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.285; BAUWRHPMUVYFOD-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; CQTRUFMMCCOKTA-UHFFFAOYSA-N; [M+H]+; 4-amino-4-methylpentan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; XESAXGZAVQQNBN-UHFFFAOYSA-N; [M+H]+; N-propan-2-yloxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.198; ZKALVNREMFLWAN-VOTSOKGWSA-N; [M+H]+; (NE)-N-(4-methylpentan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; WQVAMFRPCWXWSS-UHFFFAOYSA-N; [M+H]+; 4-(dimethylamino)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; UKANCZCEGQDKGF-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; CJIZRCHYVWNICV-UHFFFAOYSA-N; [M+H]+; 1-(3-aminopropyl)cyclopropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; LALICKHNPWZQCK-UHFFFAOYSA-N; [M+H]+; 1-(oxetan-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; NIGGRFSYIUCXTE-UHFFFAOYSA-N; [M+H]+; 3-prop-2-enoxypropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; KYSOMVASXGZGSI-UHFFFAOYSA-N; [M+H]+; N-methyl-2-prop-2-enoxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; ZMIQVKPNVDZSAI-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyloxy-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; IDBNECMSCRAUNU-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; XMPCGZCCOXWBKR-UHFFFAOYSA-N; [M+H]+; 2,2,5-trimethyl-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; NYGCBQKDTGBHSC-UHFFFAOYSA-N; [M+H]+; oxan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; CHPRFKYDQRKRRK-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; CMNRBVDFOGJTTD-UHFFFAOYSA-N; [M+H]+; 3-(cyclopropylamino)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; FLBAPNQECBHZCB-RXMQYKEDSA-N; [M+H]+; (2R)-1-(cyclopropylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; ONRQMEJUUSHNQQ-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; GYLDXXLJMRTVSS-UHFFFAOYSA-N; [M+H]+; N-butylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.030; FUEPSWDWSHCZHJ-UHFFFAOYSA-N; [M+H]+; 3-(azetidin-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; PRAYXGYYVXRDDW-UHFFFAOYSA-N; [M+H]+; piperidin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; FLGBPLJSLMGJAR-UHFFFAOYSA-N; [M+H]+; N-(2-methoxyethyl)cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; VCOJPHPOVDIRJK-LURJTMIESA-N; [M+H]+; [(2S)-1-methylpyrrolidin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.994; BFNCRQNQIOVYBQ-UHFFFAOYSA-N; [M+H]+; 3-(azetidin-3-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; LVMHSYVPSYTPQK-UHFFFAOYSA-N; [M+H]+; 3-(2-methoxyethyl)azetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; NRPKAIWKJLKCAF-UHFFFAOYSA-N; [M+H]+; 3-(1-aminocyclopropyl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; JNXFZENQJRJCPG-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; HVHWGPDMFDCKCC-UHFFFAOYSA-N; [M+H]+; 1-(ethoxymethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; XBXHCBLBYQEYTI-UHFFFAOYSA-N; [M+H]+; piperidin-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.964; VUNPWIPIOOMCPT-UHFFFAOYSA-N; [M+H]+; piperidin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.958; NQHJHACNRXGUQU-UHFFFAOYSA-N; [M+H]+; N-(2-methylbutan-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; RGNFMQJLAOONTP-UHFFFAOYSA-N; [M+H]+; 2-ethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; PDNZJLMPXLQDPL-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopentyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; VIJUZNJJLALGNJ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; ALDIUUDTUYLMIV-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-3-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; CEKVXGHJKQTHHH-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; JZXVADSBLRIAIB-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-2-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; JBQWQBSRIAGTJT-UHFFFAOYSA-N; [M+H]+; 3-ethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; JEZVIUQRUWOXRY-UHFFFAOYSA-N; [M+H]+; ethyl butanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; XSGMJDQRZDWEPW-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; ZCOIVJPCZLPQPT-UHFFFAOYSA-N; [M+H]+; 2-(oxolan-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; RPSYMAMREDJAES-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; UELHSANKOLQHTB-UHFFFAOYSA-N; [M+H]+; 1-propylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; QQOPXZDLCMWTIO-UHFFFAOYSA-N; [M+H]+; 3-propan-2-yloxyazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.915; ZEYSHALLPAKUHG-UHFFFAOYSA-N; [M+H]+; 4-methoxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; WGYZZCUTSHNMET-UHFFFAOYSA-N; [M+H]+; N-methyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; NIQIPYGXPZUDDP-UHFFFAOYSA-N; [M+H]+; 3-aminocyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; UBKOTQBYKQFINX-UHFFFAOYSA-N; [M+H]+; N-pentylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; MCZIJQYYIXXDDA-UHFFFAOYSA-N; [M+H]+; N-butyl-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; HEYGLTRAXBZNAD-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; MRWRHHSVHWCISU-UHFFFAOYSA-N; [M+H]+; 3-methoxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; IPBPLHNLRKRLPJ-UHFFFAOYSA-N; [M+H]+; oxan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; MDKHWJFKHDRFFZ-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; JKYGZQCMFANMFM-UHFFFAOYSA-N; [M+H]+; azepan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; NPWMWLAPRVMNBN-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrolidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; NZBVQPIZDGSDNN-UHFFFAOYSA-N; [M+H]+; 1,4-oxazocane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; OAQDXXYGSGJMGR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; LLDKGUNKYFJNPV-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; SWIMYOUDBYVEIN-UHFFFAOYSA-N; [M+H]+; azepan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; IEBYUZARWOFDSE-UHFFFAOYSA-N; [M+H]+; 1-pyrrolidin-2-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; UAZCJMVDJHUBIA-UHFFFAOYSA-N; [M+H]+; 6-methylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; QDPYHRSTDJTFRG-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; BJOWRJDUPYOCEU-UHFFFAOYSA-N; [M+H]+; (2-methylpyrrolidin-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; YAMQDSQNPDUGGS-UHFFFAOYSA-N; [M+H]+; 2-methylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; JMGBOXZFLWUSLH-UHFFFAOYSA-N; [M+H]+; (5-methylpyrrolidin-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; SHTKAZQCRDTBLT-UHFFFAOYSA-N; [M+H]+; (5-methylpyrrolidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; YOUDCFZQKXTNCC-NTSWFWBYSA-N; [M+H]+; [(3R,4R)-4-methylpyrrolidin-3-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; DYHXKPISQYRSST-UHFFFAOYSA-N; [M+H]+; 6-methyl-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; RJMNAMGXLRMTME-WDSKDSINSA-N; [M+H]+; [(2S,4S)-4-methylpyrrolidin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; DSVHVLZINDRYQA-PHDIDXHHSA-N; [M+H]+; (2R,4R)-2-methylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; NTMSMLWLSVNRKL-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; JDZXBVUTOWDOLV-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; HFTIGFBKBVCGPD-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; OINJJDUXGDGROO-UHFFFAOYSA-N; [M+H]+; (2,2-dimethylazetidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; CXBLQEIODBBSQD-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; OSLUBCFDADJJFO-UHFFFAOYSA-N; [M+H]+; 2-[cyclopropyl(methyl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; HQKJQSCCAMQSPY-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; JXXVNJUPCPLXJI-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; UFLFSJVTFSZTKX-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; ZTCHEOLGUZDPAN-UHFFFAOYSA-N; [M+H]+; oxan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.876; HECZPOCJWCHBHK-UHFFFAOYSA-N; [M+H]+; 4-methyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.876; NKRLLPCWCPIQPL-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-3-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; GTINRJGGSAKCEO-UHFFFAOYSA-N; [M+H]+; 3-(methoxymethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; HVQDOKDLGGYIOY-RITPCOANSA-N; [M+H]+; [(1R,3S)-3-aminocyclopentyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; ZUGRRINNTXSWBR-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(oxolan-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; LTJFPCBECZHXNS-WDSKDSINSA-N; [M+H]+; (2S,3S)-2,3-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; VJUDVVHGQMPPEI-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(oxolan-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; JFLVVCGMJYMWML-WDSKDSINSA-N; [M+H]+; [(1R,2S)-2-aminocyclopentyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; QPXXGRHIYAAMDU-UHFFFAOYSA-N; [M+H]+; 2-methyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; YAEYCYRQJINORB-PHDIDXHHSA-N; [M+H]+; (1R,2R)-2-(methylamino)cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; KEBOYHJEUFJZPE-LURJTMIESA-N; [M+H]+; (3S)-3-ethoxypyrrolidine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H14N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.293
MS$FOCUSED_ION: PRECURSOR_M/Z 116.106986
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-9200000000-501f1ba4f951f8a812a1
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544757 10.0315 55.055183 1.2896 2.70 -0.0374 17 f{C4H7}/4.52ppm,p-C2H7N1O1
  58.0653911 999.0000 58.066111 0.3272 0.00 0.6471 22 f{C3H8N1}/4.57ppm,p-C3H6O1
  59.0687316 39.8677 59.069455 0.5587 3.89 0.6716 22 ?
  69.0700320 40.5874 69.070775 0.8397 6.37 0.3603 22 f{C5H9}/2.25ppm,p-C1H5N1O1
  70.0653308 9.6956 70.066074 1.0990 2.84 0.0420 17 f{C4H8N1}/2.93ppm,p-C2H6O1
  78.9498760 10.6223 78.950609 1.5706 2.99 0.2382 20 ?
  79.0542860 49.9788 79.055018 0.5692 7.03 -0.0221 22 f{C6H7}/0.75ppm,p-H7N1O1
  79.9489870 11.3859 79.949717 0.9631 2.46 0.2235 19 ?
  80.0577052 8.5411 80.058435 1.3365 2.78 -0.0464 19 ?
  80.9451218 135.1439 80.945849 0.3706 20.94 0.2059 22 ?
  96.0807821 30.1297 96.081427 0.8743 4.21 0.1821 20 f{C6H10N1}/0.07ppm,p-H4O1
  97.0648463 11.0503 97.065483 1.2878 2.58 0.3250 20 f{C6H9O1}/0.57ppm,p-H5N1
  98.9556294 29.3365 98.956251 1.1318 5.75 0.2618 21 ?
  114.0913658 241.3604 114.091857 0.4032 35.70 0.2794 22 f{C6H12N1O1}/0.22ppm,p-H2
  115.0947837 49.5436 115.095266 0.8341 7.13 0.2672 22 ?
  116.1071770 13.5117 116.107651 0.8871 2.63 1.0000 17 f{C6H14N1O1}/1.61ppm,p
  116.9662159 102.3592 116.966683 0.5301 16.98 0.3284 22 ?
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  55.054476 10.03 10
  58.065391 999.00 999
  59.068732 39.87 39
  69.070032 40.59 40
  70.065331 9.70 9
  78.949876 10.62 10
  79.054286 49.98 49
  79.948987 11.39 11
  80.057705 8.54 8
  80.945122 135.14 135
  96.080782 30.13 30
  97.064846 11.05 11
  98.955629 29.34 29
  114.091366 241.36 241
  115.094784 49.54 49
  116.107177 13.51 13
  116.966216 102.36 102
//
